NEW YORK — Pfizer Inc. is spinning off its animal health business into a separate company that will be called Zoetis (Zoe-EHT-iss).
The world's biggest drug maker previously announced that it would either spin off or otherwise divest the business between this July and July 2013.
“Pfizer Animal Health is a dynamic business with strong fundamentals, an expanding and loyal direct customer base and a proven management team,” said Ian Read, chairman and chief executive officer, Pfizer. “We are on track to create a standalone animal health company by our previously stated target of July 2013. Our focus. . .
Register or Login to keep reading
Thank you for your interest in accessing the complete content. To continue reading, please register for free. By registering, you'll gain full access to our valuable resources, updates, and insights.
If you already have an account please Log In.
